# A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy

> **NCT07628738** · PHASE2 · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 39 (estimated)

## Conditions studied

- Lymphoma (Non-Hodgkin's Lymphoma)

## Interventions

- **RADIATION:** reduced-intensity radiotherapy

## Key facts

- **NCT ID:** NCT07628738
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2032-05-01
- **Final completion:** 2034-05-01
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2026-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07628738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07628738, "A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07628738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*